Literature DB >> 10579063

Magnetic resonance imaging in acute myocardial infarction.

K C Wu1, C E Rochitte, J A Lima.   

Abstract

Advances in magnetic resonance imaging (MRI) have led to more widespread utilization of this diagnostic imaging modality in the diagnosis of coronary artery disease. With MRI, the complexity and heterogeneity of myocardial infarcts can be demonstrated. By using this technique, much insight has been gained into the pathophysiologic mechanisms of acute coronary thrombosis and reperfusion. MRI has significant diagnostic potential, particularly if one can combine studies of myocardial function, perfusion, and sodium metabolism with the noninvasive assessment of coronary anatomy and epicardial coronary artery blood flow.

Entities:  

Mesh:

Year:  1999        PMID: 10579063     DOI: 10.1097/00001573-199911000-00005

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  3 in total

1.  Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement.

Authors:  Peter Kellman; Andrew E Arai; Elliot R McVeigh; Anthony H Aletras
Journal:  Magn Reson Med       Date:  2002-02       Impact factor: 4.668

2.  Diagnostic value of routine clinical parameters in acute myocardial infarction: a comparison to delayed contrast enhanced magnetic resonance imaging. Delayed enhancement and routine clinical parameters after myocardial infarction.

Authors:  Steffen E Petersen; Georg Horstick; Thomas Voigtländer; Karl-Friedrich Kreitner; Thomas Wittlinger; Steffen Ziegler; Nico Abegunewardene; Melanie Schmitt; Wolfgang G Schreiber; Peter Kalden; Oliver K Mohrs; Manfred Thelen; Juergen Meyer
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

3.  Longitudinal strain is a marker of microvascular obstruction and infarct size in patients with acute ST-segment elevation myocardial infarction.

Authors:  Loïc Bière; Erwan Donal; Gwenola Terrien; Gaëlle Kervio; Serge Willoteaux; Alain Furber; Fabrice Prunier
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.